3-MA was recently identified as an anti-cachectic and anti-tumorigenic factor in pancreatic cancer acting through inhibition of p53 apoptosis effector related to PMP22 (PERP) and suppression of pancreatic cancer cell growth [58]. This evidence concerns the gene TP53 and familial pancreatic carcinoma.